SESSION TYPE: COPD Posters I
PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM
PURPOSE: There is a situation that COPD is estimated to currently have still not widely recognized. And also COPD (written in English) is not yet widely recognized in Japan. So, in this study, aimed at improving patient's understanding, education and improvement of above situation.
METHODS: Subjects (n=27) in a survey conducted in who admitted to a certain hospital that freshly diagnosed patients (COPDΙ - ΙΙ°). Face-to-face interview technique and distribution of materials. Disease name use COPD and TOBACCO BYOU that is Abbreviation word<Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease) 3rd edition (The Japanese Respiratory Society) Chronic Obstructive Pulmonary Disease: Japanese official disease name MANSEI HEISOKUSEI HAISIKKAN>.
RESULTS: At the beginning of the study, the patients which can be answered clearly the name of the own disease were few (11.1%). The name of the disease had can be recognized gradually as the number of times of our repeatedly face-to-face guidance. The proportion of the disease which can be answered precisely in the fourth times, exceeded 60%. Understanding of the disease name was increased the patients that interested in the importance of their own disorder. Group that was not able to answer the name of disease were often elderly, and we considered that should be also to implement a combination of guidance to their family. Particularly, many of them were understand as a Japanese name.
CONCLUSIONS: Early stage, age, were one of factors of the slow recognition COPD that their own disease. This study was considered more effective for the treatment and education for patient. It might be worthwhile to educate the patient to understand their disease COPD together with own easy native language. After understanding the disease(of course continue education), and we should investigate necessary to aimed at improving adherence and avoidance of acute exacerbation.
CLINICAL IMPLICATIONS: Requires the certain amount of time to understanding the disease of COPD patients is correct.
DISCLOSURE: The following authors have nothing to disclose: Tomoyasu Uno
No Product/Research Disclosure InformationHealth Care Center, Fukushima University, Fukushima, Japan